SUBSEQUENT EVENTS (Details) (Subsequent Event [Member])	6 Months Ended
	Jun. 30, 2012
Subsequent Event [Line Items]
Subsequent event date	Jul. 30, 2012
Number of patients enrolled for open-label phase IIIb trial by Auxilium	60
Number of sites throughout U.S. and Australia at which patients were enrolled for open-label phase IIIb trial	8
Number of cords treated concurrently in Dupuytren's surgeries, minimum	2
Minimum [Member]
Subsequent Event [Line Items]
Percentage of annual Dupuytren's surgeries in the US performed to treat two or more cords concurrently	35.00%
Maximum [Member]
Subsequent Event [Line Items]
Percentage of annual Dupuytren's surgeries in the US performed to treat two or more cords concurrently	40.00%